CCM
VRDN icon

Cinctive Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Cinctive Capital Management’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$225K Sell
11,480
-50,289
-81% -$1.49M 0.01% 344
2025
Q4 		$1.92M Buy
+61,769
New +$1.69M 0.1% 213
2024
Q4 		– Sell
-26,541
Closed -$604K – 496
2024
Q3 		$604K Sell
26,541
-20,707
-44% -$339K 0.03% 329
2024
Q2 		$615K Buy
47,248
+6,390
+16% +$88.5K 0.03% 342
2024
Q1 		$715K Sell
40,858
-310
-0.8% -$6.01K 0.03% 318
2023
Q4 		$897K Buy
+41,168
New +$650K 0.06% 261

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return